GlassScriptPhysician profile
Dennis M Jacob
NPI 1245262054
$4,496.57
in general payments reported to CMS, 2019-2025
11 companies · $302 in 2025
The $302 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $219 · 2021: $709 · 2022: $1,771 · 2023: $1,325 · 2024: $21.39 · 2025: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,649.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,649.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,582.44 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $853.78 | 2019-2023 | Gore Tag Conformable Thoracic Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Boston Scientific Corporation | $574.44 | 2021-2025 | Enroute Transcarotid Neuroprotection System |
| Philips North America LLC | $568.33 | 2022-2023 | |
| Endologix LLC | $219.01 | 2020 | |
| Abbott Laboratories | $186.12 | 2023 | Diamondback Peripheral, Diamondback Coronary |
| Inari Medical, INC. | $185.50 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Silk Road Medical, INC. | $177.57 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Shockwave Medical, INC | $117.09 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novo Nordisk INC | $21.39 | 2024 | Wegovy |
| Pfizer INC. | $10.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Jacob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.